Magnetar Financial LLC Halozyme Therapeutics, Inc. Transaction History

Magnetar Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $183,507 - $235,684	-5,740 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $302,799 - $387,777	-9,516 Reduced 62.38%	5,740 $231,000
Q3 2021 Nov 12, 2021	BUY	$38.47 - $46.42 $586,898 - $708,183	15,256 New	15,256 $621,000
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $186,565 - $293,002	-13,422 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$14.93 - $19.53 $200,390 - $262,131	13,422 New	13,422 $238,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.